- Home
- BHE vs VERA Comparison
BHE vs VERA Comparison
Compare BHE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHE
- VERA
- Stock Information
- Founded
- BHE 1979
- VERA 2016
- Country
- BHE United States
- VERA United States
- Employees
- BHE N/A
- VERA N/A
- Industry
- BHE Electrical Products
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- BHE Technology
- VERA Health Care
- Exchange
- BHE Nasdaq
- VERA Nasdaq
- Market Cap
- BHE 1.4B
- VERA 1.4B
- IPO Year
- BHE 1990
- VERA 2021
- Fundamental
- Price
- BHE $40.56
- VERA $21.29
- Analyst Decision
- BHE Strong Buy
- VERA Buy
- Analyst Count
- BHE 2
- VERA 8
- Target Price
- BHE $46.50
- VERA $64.29
- AVG Volume (30 Days)
- BHE 262.1K
- VERA 1.8M
- Earning Date
- BHE 10-29-2025
- VERA 08-05-2025
- Dividend Yield
- BHE 1.64%
- VERA N/A
- EPS Growth
- BHE N/A
- VERA N/A
- EPS
- BHE 1.05
- VERA N/A
- Revenue
- BHE $2,588,733,000.00
- VERA N/A
- Revenue This Year
- BHE $0.18
- VERA N/A
- Revenue Next Year
- BHE $6.65
- VERA N/A
- P/E Ratio
- BHE $39.62
- VERA N/A
- Revenue Growth
- BHE N/A
- VERA N/A
- 52 Week Low
- BHE $30.73
- VERA $18.53
- 52 Week High
- BHE $52.57
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- BHE 54.99
- VERA 53.81
- Support Level
- BHE $40.69
- VERA $21.15
- Resistance Level
- BHE $41.52
- VERA $22.76
- Average True Range (ATR)
- BHE 1.04
- VERA 1.05
- MACD
- BHE 0.20
- VERA 0.16
- Stochastic Oscillator
- BHE 74.67
- VERA 62.11
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.